NM_004493.3:c.634A>G
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 10P and 1B. PM2PP5_Very_StrongBP4
The NM_004493.3(HSD17B10):c.634A>G(p.Lys212Glu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. K212K) has been classified as Likely benign.
Frequency
Consequence
NM_004493.3 missense
Scores
Clinical Significance
Conservation
Publications
- HSD10 mitochondrial diseaseInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen
- HSD10 disease, infantile typeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- HSD10 disease, neonatal typeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- syndromic X-linked intellectual disability type 10Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004493.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HSD17B10 | NM_004493.3 | MANE Select | c.634A>G | p.Lys212Glu | missense | Exon 6 of 6 | NP_004484.1 | ||
| HSD17B10 | NM_001037811.2 | c.607A>G | p.Lys203Glu | missense | Exon 6 of 6 | NP_001032900.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HSD17B10 | ENST00000168216.11 | TSL:1 MANE Select | c.634A>G | p.Lys212Glu | missense | Exon 6 of 6 | ENSP00000168216.6 | ||
| HSD17B10 | ENST00000375304.9 | TSL:1 | c.607A>G | p.Lys203Glu | missense | Exon 6 of 6 | ENSP00000364453.5 | ||
| HSD17B10 | ENST00000477706.1 | TSL:3 | n.258A>G | non_coding_transcript_exon | Exon 3 of 3 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
not provided Pathogenic:2
HSD17B10: PM1, PM2, PS3:Moderate, PS4:Supporting
Introduction of the K212E variant into E. coli found that it is associated with significantly reduceddehydrogenase activity of the SDR5C1 enzyme compared to wild-type (Falk et al., 2016).Additional functional analysis found that the K212E variant also results in impaired 5' processingand methylation of mt-tRNAs (Falk et al., 2016). The K212E variant is located with the substratespecificity loop and is predicted to alter active site closure of the SDR5C1 enzyme (Falk et al.,2016). The K212E variant was not observed in approximately 6,500 individuals of European andAfrican American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a commonbenign variant in these populations. The K212E variant is a non-conservative amino acidsubstitution, which is likely to impact secondary protein structure as these residues differ inpolarity, charge, size and/or other properties. This substitution occurs at a position that isconserved across species. In silico analysis is inconsistent in its predictions as to whether or notthe variant is damaging to the protein structure/function. In summary, we interpret K212E to be apathogenic variant.
HSD10 mitochondrial disease Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at